AC Immune rises after amending licensing deal with Lilly
Source: SeekingAlpha
2026-04-07 10:45:33 ET
More on AC Immune, Eli Lilly
- Eli Lilly's Centessa Deal Shows It Is Awake To New Narcolepsy Reality
- Novo Nordisk Vs. Eli Lilly: Cheap Vs. Expensive, But No Clear Opportunity
- AC Immune FY 2025 Results: Eyeing ACI-7104 Catalysts
- Novo Nordisk CEO says weight-loss drug boom has barely begun
- Most and least shorted mid-to mega-cap healthcare stocks in March
Read the full article on Seeking Alpha
For further details see:
AC Immune rises after amending licensing deal with Lilly
AC Immune SA
NASDAQ: ACIU
ACIU Trading
-4.82% G/L:
$2.27 Last:
199,846 Volume:
$2.39 Open:
ACIU Latest News
ACIU Stock Data
$309,766,013
46,088,363
N/A
39
N/A
Biotechnology & Life Sciences
Healthcare
CH
Lausanne
